U.S. development pipeline includes almost 400 infectious disease drugs

12/16/2013 | PharmTech.com

PhRMA has reported that 394 drugs and vaccines are being developed by U.S. biopharmaceutical companies. The treatments, either under review by the FDA or in clinical trials, include 15 medicines for parasitic infections, 24 for fungal infections, 124 for bacterial infections and 226 for viral infections.

View Full Article in:

PharmTech.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
PacificSource
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA